About: Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
Creator	Mentis, Andreas Karofylakis, Emmanouil Terpos, Evangelos Dimopoulos, Kaparelou, M Kaparelou, Maria Karofylakis, E Kavatha, D Kavatha, Dimitra Liontos, M Liontos, Michalis Mentis, A Zagouri, F Zagouri, Flora
source	Elsevier; Medline; PMC
abstract	• Chemotherapy resumption after convalescence from COVID-19 is safe and feasible. • No guidelines exist for resumption of chemotherapy in patients with COVID-19. • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.
has issue date	2020-07-30(xsd:dateTime)
bibo:doi	10.1016/j.gore.2020.100615
bibo:pmid	32766415
has license	no-cc
sha1sum (hex)	8d14b0982c1e64e074b99e46a62016301508a11f
schema:url	https://doi.org/10.1016/j.gore.2020.100615
resource representing a document's title	Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
has PubMed Central identifier	PMC7390730
has PubMed identifier	32766415
schema:publication	Gynecol Oncol Rep
resource representing a document's body	covid:8d14b0982c1e64e074b99e46a62016301508a11f#body_text
is schema:about of	named entity 'COVID-19' named entity 'electrocardiogram' named entity 'Diarrhea' named entity 'non-smoker' named entity 'neutrophils' named entity 'chemotherapy' named entity 'ovarian cancer' named entity 'leukocytes' named entity 'serous' named entity '20 months' named entity 'medical history' named entity 'oncological' named entity 'abdominal discomfort' named entity 'COVID-19' named entity 'management of cancer' named entity 'ambient air' named entity 'leukocytosis' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'bowel obstruction' named entity 'LDH' named entity 'CRP' named entity 'hydroxychloroquine' named entity 'diarrhea' named entity 'carvedilol' named entity 'SARS-Cov-2' named entity 'pleural effusion' named entity 'urine cultures' named entity 'breath sounds' named entity 'fever' named entity 'morbidity' named entity 'emergency department' named entity 'enoxaparin' named entity 'chronic illnesses' named entity 'enzyme immunoassay' named entity 'neutrophilia' named entity 'CT scan' named entity 'costophrenic angle' named entity '120 beats per minute' named entity 'lung lobe' named entity 'procalcitonin' named entity 'atrial fibrillation' named entity 'Carboplatin' named entity 'C-Reactive protein' named entity 'March 28' named entity 'COVID-19 pandemic' named entity 'chest X-Ray' named entity 'A60' named entity 'afebrile' named entity 'pulmonary auscultation' named entity 'COVID' named entity 'pleurodesis' named entity 'blood pressure' named entity 'Paclitaxel' named entity 'PCR' named entity 'piperacillin-tazobactam' named entity 'azithromycin' named entity 'PCR' named entity 'ovarian cancer' named entity 'refractory disease' named entity 'pleural effusion' named entity 'COVID-19 pandemic' named entity 'pneumonia' named entity 'chemotherapy' named entity 'ovarian cancer' named entity 'debulking' named entity 'Bevacizumab' named entity 'fever'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software